Aging and Estrogenic Control of the Bioenergetic System in Brain
Aging and Estrogenic Control of the Bioenergetic System in Brain
批准号:
10405726
负责人:
ROBERTA EILEEN BRINTON
金额:
$53.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-03-15 至 2027-03-31
关键词:
AddressAgeAgingAlzheimer&aposs DiseaseBioenergeticsBrainClinicalDataEstradiolEstrogen Receptor alphaEstrogensFaceFeedbackFemaleFeminizationGene ExpressionGene Expression ProfileGenerationsGenetic TranscriptionGenomicsGlucoseGoalsHormonesLeadMenopauseMental DepressionMetabolicMitochondriaMonitorMultiple SclerosisNeurodegenerative DisordersNeurologicNeuronsNuclearOutcomeOxidation-ReductionPathway interactionsPatternPerformancePostmenopausePrevalenceProcessProtein IsoformsPublic HealthRegulationRegulatory PathwayResearchRespirationRiskRoleSeriesSignal TransductionSystemSystems BiologyTestingTimeTranscriptional RegulationWomanWomen&aposs Healthage relatedagedaging brainaging populationcell growth regulationcell typeclinically significantdesigndisorder riskestrogenicfunctional outcomesglucose metabolismglucose transportinsightmenmind controlmitochondrial genomenervous system disorderprogramsreproductiveresponsetherapeutic target
中文摘要
我们早期对雌激素在大脑中作用的机制分析导致发现雌激素是主宰。
大脑中生物能量系统的调节器,促进葡萄糖的运输,葡萄糖代谢,
线粒体呼吸和三磷酸腺苷的生成。总的来说,这些数据为雌激素提供了令人信服的证据。
作为系统生物学在脑中的代谢调节器,阐明了与
一个正在挨饿的老化女性大脑。雌激素作为生物能量系统的主要调节器发挥作用
在女性大脑中,雌激素必须整合核和线粒体基因组反应。更远的距离
从系统水平的角度来看,雌激素也有必要调节细胞质信号
实时反馈核和线粒体基因转录功能结果的机制。
要研究的基本问题是雌激素结合生物能量的机制。
跨两个基因组隔间的响应,同时监控能量需求和
实时性能。拟议的研究计划旨在检验两个假设。第一,
雌激素控制女性大脑中的生物能量系统需要:1)核和线粒体
基因组;2)跨基因组区段的基因表达的整合;3)快速激活
信号级联以提供对生物能量性能的实时反馈。第二,我们假设
衰老女性大脑中雌激素的丢失导致核内雌激素调控的系统性解体
线粒体基因组随之而来的是生物能量感知机制的下降。雌激素的调控作用
脑的生物能量系统及其拆解具有基础性、转化性和临床意义。
从发现的角度来看,提出的研究方案在探索机制方面是独一无二的
核和线粒体基因表达的雌激素整合及其实时反馈
控制大脑生物能量系统的机制。此外,这种控制的过程
系统解体在老年女性大脑中是未知的领域,对理解具有很高的意义
大脑中的生物能量老化。翻译过来,就是确定系统性拆解背后的机制
脑内生物能量室雌激素整合的研究具有检测治疗靶点的潜力
在老化的女性大脑中维持生物能量功能。临床上,更年期的衰老过渡,是独一无二的
女性,是一个同时破坏大脑的生殖能力和潜在的生物能量能力的过程。
这尤其与年龄相关的神经系统疾病与葡萄糖缺乏有关。
低代谢症,如阿尔茨海默氏症、抑郁症和多发性硬化症,在
绝经后的女性。本文建议的研究符合NIA战略研究目标A和C以及
“需要更好地区分大脑老化的模式”https://www.nia.nih.gov/about/living-long-well-21st-
世纪-战略方向-研究-老龄化和妇女健康研究办公室的目标。
英文摘要
Our earlier mechanistic analyses of estrogen action in brain led to the discovery that estrogen is a master
regulator of the bioenergetic system in brain that promotes glucose transport, glucose metabolism,
mitochondrial respiration and ATP generation. Collectively, the data provided compelling evidence for estrogen
as a systems biology metabolic regulator in brain and illuminated compensatory mechanisms consistent with
an aging female brain that is starving. For estrogen to function as master regulator of the bioenergetic system
in the female brain, estrogen must be integrating nuclear and mitochondrial genomic responses. Further from a
systems level perspective, it would be necessary for estrogen to also regulate cytoplasmic signaling
mechanisms for real time feedback on the functional outcomes of nuclear and mitochondrial gene transcription.
The fundamental issues to be investigated are the mechanisms whereby estrogen integrates bioenergetic
responses across two genomic compartments while simultaneously monitoring energetic demand and
performance in real time. The proposed program of research is designed to test two hypotheses. First,
estrogenic control of the bioenergetic system in the female brain requires: 1) both nuclear and mitochondrial
genomes; 2) integration of gene expression across both genomic compartments and 3) activation of rapid
signaling cascades to provide real time feedback on bioenergetic performance. Second, we hypothesize that
loss of estrogen in the aging female brain leads to a systematic dis-integration of estrogenic control of nuclear
and mitochondrial genomes followed by decline in bioenergetic sensing mechanisms. Estrogenic control of the
bioenergetic system of the brain and the dismantling thereof has basic, translational and clinical significance.
From a discovery perspective the proposed program of research is unique in exploring the mechanisms
underlying estrogenic integration of nuclear and mitochondrial gene expression and the real time feedback
mechanisms that control the bioenergetic system of the brain. Further, the process by which this control
system is dismantled in the aging female brain is uncharted territory of high significance for understanding
bioenergetic aging in brain. Translationally, determining the mechanisms underlying the systematic dismantling
of estrogenic integration of bioenergetic compartments in brain has the potential to detect therapeutic targets to
sustain bioenergetic function in the aging female brain. Clinically, the aging transition of menopause, unique to
the female, is a process that dismantles both reproductive ability and potentially bioenergetic capacity in brain.
This is particularly relevant to age-related neurological conditions associated with deficits in glucose
hypometabolism such as Alzheimer's, depression and multiple sclerosis which have greater prevalence in
postmenopausal women. Research proposed herein aligns with NIA Strategic Research Goals A and C and
the “need to better distinguish patterns of brain aging” https://www.nia.nih.gov/about/living-long-well-21st-
century-strategic-directions-research-aging and to objectives of Office of Research on Women's Health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Research in Alzheimer's Disease and related Dementias (TRADD)
-
批准号:10709167
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2023
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Novel Intranasal Formulations of Allopregnanolone, a Regenerative Therapeutic for Alzheimer's Disease
-
批准号:10698555
-
项目类别:
-
资助金额:$50.58万
-
财政年份:2023
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
-
批准号:10560591
-
项目类别:
-
资助金额:$154.45万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
-
批准号:10547639
-
项目类别:
-
资助金额:$133.74万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
-
批准号:10344556
-
项目类别:
-
资助金额:$212.12万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
-
批准号:10707107
-
项目类别:
-
资助金额:$119.93万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10689308
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Research Education Component
-
批准号:10264194
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10491851
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10270190
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10199069
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:9991710
-
项目类别:
-
资助金额:$737.08万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Novel formulations of Allopregnanolone to treat Alzheimer's Disease
-
批准号:9906039
-
项目类别:
-
资助金额:$44.99万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:10411886
-
项目类别:
-
资助金额:$755.24万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:10674824
-
项目类别:
-
资助金额:$728.0万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:9793963
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10437663
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10645075
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Sex Differences in the Molecular Determinants of Alzheimer's Disease Risk: Prodromal Endophenotype
-
批准号:9770740
-
项目类别:
-
资助金额:$114.13万
-
财政年份:2018
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Translational Research in AD and related Dementias (TRADD)
-
批准号:10475657
-
项目类别:
-
资助金额:$20.87万
-
财政年份:2018
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: